Alphabet's Verily gets FDA's OK for ECG function in clinical studies

CNET | 1/18/2019 | Abrar Al-Heeti
melanie7 (Posted by) Level 3
Click For Photo: https://cnet2.cbsistatic.com/img/LCX4QduVIcNgErljR2Am8pbb3no=/724x407/2019/01/18/f6c5b58e-4229-4abc-ac55-aec36920478e/study-watch-clearance.png

The Verily Study Watch has received FDA clearance.

Verily, Alphabet's life sciences arm, said Friday that it's received FDA clearance for an ECG feature on its Verily Study Watch.

Part - Google - Parent - Company - Alphabet

Verily, part of Google parent company Alphabet, launched the Verily Study Watch in April 2017 to collect health information from clinical research participants. The watch has been used by thousands of participants in clinical research studies, according to the company. Verily says unobtrusive biosensing using devices like Study Watch could help to understand what's happening in the body at a given time, as well as how our bodies stay healthy or change with disease.

One area Verily has focused on with Study Watch is cardiovascular health. The watch includes an electrocardiogram, or ECG, feature, which measures the electrical activity of the heart and can help diagnose a variety...
(Excerpt) Read more at: CNET
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!